跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
IS-741
首页
药物
IS-741
IS-741
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Isolated polynucleotides and polypeptides and methods of using same for increasing plant utility
申请人: EMMANUEL EYAL
优先权: 2009
US
6 件公开
Polypeptide-vaccines for broad protetion against hypervirulent meningococcal lineages
申请人: CHIRON SPA
优先权: 2002
CN
US
4 件公开
NOVEL ANDROGEN RECEPTOR MUTATION
申请人: NOVARTIS AG
优先权: 2013
CN
EP
2 件公开
Factor VIII polypeptide
申请人: IN2GEN CO LTD
优先权: 2003
US
2 件公开
Preparation for breast cancer monoclonal antibody M4G3 single-chain antibody and DNA sequence thereof
申请人: TIANJIN MEDICAL UNEVERSITY CANCER HOSPITAL
优先权: 2006
CN
Composition for the treatment of burns, diabetic wounds, other types of wounds and subsequently greatly reduced scarring
申请人: ISANAKA RAM
优先权: 2015
US
Gene VvMADS39 for regulating grape seed development and application thereof
申请人: UNIV NORTHWEST A&F
优先权: 2020
CN
Construction method and application of Danon disease mouse disease model
申请人: ZHONGSHAN HOSPITAL FUDAN UNIV
优先权: 2024
CN
PtoNAC90 gene for regulating formation of poplar wood and application of PtoNAC90 gene
申请人: UNIV BEIJING FORESTRY
优先权: 2025
CN
741 poplar PtoWRKY24 gene promoter responding to multiple stress and application of 741 poplar PtoWRKY24 gene promoter
申请人: UNIV HEBEI AGRICULTURE
优先权: 2025
CN
药物
反馈